Press Releases on August 12, 2024 - EIN Presswire - Press Release Distribution Service

Published on August 12, 2024 - 12:00 GMT

Hopebridge Continues to Grow Autism Therapy Services by Opening a New Location in Ohio

INDIANAPOLIS, IN, Aug. 12, 2024 (GLOBE NEWSWIRE) -- As the prevalence of autism increases and the national focus is placed on early identification and intervention, Hopebridge Autism Therapy Centers is bringing its innovative mix of multidisciplinary …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 12, 2024 - 12:00 GMT

MBX Biosciences Doses First Patient in Phase 2 Avail™ Trial of MBX 2109 for the Treatment of Hypoparathyroidism

CARMEL, Ind., Aug. 12, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today …

Distribution channels: Technology ...

Published on August 12, 2024 - 12:00 GMT

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

VANCOUVER, Wash. and NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Today, Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK), a leading cancer …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 12, 2024 - 12:00 GMT

4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on August 12, 2024 - 12:00 GMT

Yoshitsu Co., Ltd Establishes Franchise Network for Southeast Asia Expansion

TOKYO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Yoshitsu Co., Ltd ("Yoshitsu" or the "Company") (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, as well as …

Distribution channels: Business & Economy, Retail ...

Published on August 12, 2024 - 12:00 GMT

New Research Reveals Major Disparities in Access to Living Wages in U.S. Workforce

MINNEAPOLIS and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today launched its inaugural Dayforce Living Wage Index, conducted in partnership …

Distribution channels: Science, Technology ...

Published on August 12, 2024 - 12:00 GMT

New National Chuck E. Cheese Fun Pass Membership Program Offers Unlimited Visits for as Low as $7.99 a Month

Families can now enjoy unlimited visits to Chuck E. Cheese year-round with a low monthly fee. Three membership tiers are available, offering 40 to 250 games per visit, plus 20% to 50% off most food and drinks. Two-Month Fun Passes with the same benefits …

Distribution channels: Food & Beverage Industry, Media, Advertising & PR ...

Published on August 12, 2024 - 12:00 GMT

Navigate360 Launches Free Self-Harm Intervention Tool for K-12 Schools Nationwide

RICHFIELD, OHIO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- In response to recent tragic events and the escalating mental health crisis among students, Navigate360 announces a commitment to partner with schools across America in a pledge to achieve Zero Incidents …

Distribution channels: Media, Advertising & PR ...

Published on August 12, 2024 - 12:00 GMT

Avalyn Announces Initiation of Phase 1b Clinical Study for AP02, its Novel Inhaled Nintedanib

CAMBRIDGE, Mass., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for treatment of life-threatening pulmonary diseases, today announced the initiation of its …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 12, 2024 - 12:00 GMT

CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

- Completed enrollment in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with early-stage dementia with Lewy bodies (DLB) in June 2024; topline data expected in December 2024 - - Hosted a virtual key opinion leader event in July …

Distribution channels:

Published on August 12, 2024 - 12:00 GMT

Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer

-- Highly-experienced hematologist and oncologist with proven track record successfully driving global clinical development of CAR-T cell therapies -- BERKELEY, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading …

Distribution channels: Companies ...

Published on August 12, 2024 - 12:00 GMT

Synchronoss Technologies to Present at the Sidoti Virtual Investor Conference

BRIDGEWATER, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, today announced that Jeff Miller, President and CEO, and Louis …

Distribution channels: Culture, Society & Lifestyle, IT Industry ...

Published on August 12, 2024 - 12:00 GMT

Westwood Hires Chris Doran as Head of ETF Distribution & National Accounts

Highly experienced senior sales leader Doran underscores Westwood’s commitment to further expanding its exchange-traded fund (ETF) platform Doran has a 25-year proven track record in ETF sales in the financial intermediary channel DALLAS, Aug. 12, 2024 ( …

Distribution channels: Companies ...

Published on August 12, 2024 - 12:00 GMT

Shoals Technologies Group Appoints Niharika Taskar Ramdev to Its Board of Directors

PORTLAND, Tenn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Nasdaq: SHLS), a global leader in electrical balance of systems (EBOS) solutions for the energy transition market, today announced that its Board of Directors has appointed …

Distribution channels: Companies, Technology ...

Published on August 12, 2024 - 12:00 GMT

UNITY Biotechnology to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that members of its senior management team will …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on August 12, 2024 - 12:00 GMT

Aeries Technology Selected by Diligent to Establish a Customer Success Center of Excellence in Guadalajara

NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional services and technology consulting partner, today announced that it has been selected by Diligent, a leading GRC SaaS …

Distribution channels:

Published on August 12, 2024 - 12:00 GMT

Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update

Completed enrollment of the 150 patients in the COMPANION-002 Study, a Phase 2/3 trial of CTX-009 (DLL4 and VEGF-A bispecific antibody) plus paclitaxel versus paclitaxel monotherapy in patients with previously treated, unresectable advanced metastatic or …

Distribution channels:

Published on August 12, 2024 - 12:00 GMT

Mindera Health Announces Appointment of Kamal Adawi as Chief Financial Officer

San Diego, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Ron Rocca, President and CEO of Mindera Health, said, “We’re very pleased to add Kamal to the executive team. I am thrilled to work with Kamal again as he will add the strategic focus and long-term financial …

Distribution channels: Media, Advertising & PR ...

Published on August 12, 2024 - 12:00 GMT

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 13, 2024

DURHAM, N.C., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the …

Distribution channels:

Published on August 12, 2024 - 12:00 GMT

Annexon Reports Second Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

Single, Well-Tolerated Infusion of ANX005 Significantly Accelerated Recovery of GBS Patients vs. Placebo in Pivotal Phase 3 Trial; Potential to be First Targeted Therapy for GBS; Topline Real-World Evidence (RWE) Comparability Data Now Expected by Year-End …

Distribution channels: